arrow
Q

Qin Ning

hubei provincial clinical study center of viral hepatitis
H指数:53
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper

全球关于急性-on-慢性肝衰竭患者重症监护管理的共识:APASL ACLF北京立场文件

2026-07-300
PRE
Efficacy and safety of entecavir, peginterferon alfa-2b and GM-CSF combination therapy: the anchor randomized controlled trial

恩替卡韦、聚乙二醇干扰素α-2b和GM-CSF联合疗法的有效性与安全性:ANCHOR随机对照试验

2025-12-090
OAAI
Safety and efficacy of GST-HG141, a novel HBV capsid assembly modulator, for the treatment of chronic hepatitis B patients with low-level viremia: a randomized, double-blind, placebo-controlled, multicenter phase II study

GST-HG141的安全性和有效性,一种新型的HBV衣壳组装调节剂,用于治疗低病毒血症的慢性乙型肝炎患者:一项随机、双盲、安慰剂对照、多中心II期研究

2025-08-020
PREAI
External Validation of the GOLDEN Model for Predicting HBsAg Loss in Noncirrhotic Chronic Hepatitis B Patients With Interferon-Alpha-Based Therapy

GOLDEN模型在预测非肝硬化慢性乙型肝炎患者经干扰素-α为基础治疗后的HBsAg消失的外部验证

2025-06-230
PRE
Acute-on-chronic liver failure (ACLF): the 'Kyoto Consensus'-steps from Asia

急慢性肝衰竭(ACLF):来自亚洲的“京都共识”进展

2025-02-170
OAAI
Development and validation of a novel mortality risk stratification simplified scoring scale for severe fever with thrombocytopenia syndrome

严重发热伴血小板减少综合征新型死亡风险分层简化评分量表的制定与验证

2025-02-060
PRE
Evaluation of Plasma Neurodegenerative Biomarkers for Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy in Chinese Patients with Hepatic Cirrhosis

血浆神经变性生物标志物对肝硬化患者轻微肝性脑病的诊断价值及对显性肝性脑病的预测价值

2024-12-121
OAAI